Bridger Management, LLC Tg Therapeutics, Inc. Transaction History

Bridger Management, LLC

$196 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $2.16 Million - $5.04 Million	-141,997 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $1.68 Million - $3.12 Million	-77,200 Reduced 35.22%	141,997 $4.73 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $1.23 Million - $1.85 Million	-37,700 Reduced 14.68%	219,197 $8.5 Million
Q3 2020 Nov 16, 2020	SELL	$18.49 - $27.24 $8 Million - $11.8 Million	-432,924 Reduced 62.76%	256,897 $6.88 Million
Q2 2020 Aug 14, 2020	SELL	$8.9 - $21.84 $1.41 Million - $3.46 Million	-158,400 Reduced 18.67%	689,821 $13.4 Million
Q1 2020 May 15, 2020	SELL	$7.14 - $15.99 $7.56 Million - $16.9 Million	-1,059,271 Reduced 55.53%	848,221 $8.35 Million
Q4 2019 Feb 14, 2020	SELL	$5.1 - $11.2 $2.18 Million - $4.78 Million	-426,704 Reduced 18.28%	1,907,492 $21.2 Million
Q3 2019 Nov 14, 2019	SELL	$5.38 - $8.99 $5.81 Million - $9.71 Million	-1,080,472 Reduced 31.64%	2,334,196 $13.1 Million
Q2 2019 Aug 14, 2019	SELL	$6.27 - $8.65 $3.69 Million - $5.09 Million	-588,813 Reduced 14.71%	3,414,668 $29.5 Million
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $852,038 - $1.7 Million	211,950 Added 5.59%	4,003,481 $32.2 Million
Q4 2018 Feb 14, 2019	BUY	$3.44 - $5.76 $5.51 Million - $9.22 Million	1,601,446 Added 73.12%	3,791,531 $15.5 Million
Q2 2018 Aug 14, 2018	SELL	$12.5 - $15.0 $2.3 Million - $2.76 Million	-183,835 Reduced 7.74%	2,190,085 $28.8 Million
Q1 2018 May 15, 2018	SELL	$8.7 - $16.8 $17.6 Million - $33.9 Million	-2,017,714 Reduced 45.94%	2,373,920 $33.7 Million
Q4 2017 Feb 14, 2018	SELL	$7.35 - $12.3 $6.64 Million - $11.1 Million	-903,410 Reduced 17.06%	4,391,634 $36 Million
Q3 2017 Nov 14, 2017	BUY	$10.0 - $12.7 $53 Million - $67.2 Million	5,295,044	5,295,044 $62.7 Million

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$484 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$358 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$286 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$113 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$101 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.57B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.

Account